Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.7% | −6.9% | −7.6% | −14.6% | +15.1% | +23.0% | +98.4% | +11.5% | +116.0% | +765.8% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$23 of every $1,000 in XBI is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 2.31% | $230.69 | 1.1M | $222.3M |
| 2 | TGTXTG Therapeutics | Healthcare | 1.87% | $186.59 | 2.8M | $179.8M |
| 3 | BIIBBiogen | Healthcare | 1.84% | $184.01 | 717K | $177.3M |
| 4 | GILDGilead Sciences | Healthcare | 1.80% | $179.71 | 1.0M | $173.2M |
| 5 | REGNRegeneron Pharmaceuticals | Healthcare | 1.79% | $179.50 | 188K | $173.0M |
| 6 | EXELExelixis | Healthcare | 1.77% | $177.38 | 2.6M | $170.9M |
| 7 | ABBVAbbvie | Healthcare | 1.77% | $177.32 | 603K | $170.9M |
| 8 | SYRESpyre Therapeutics | Healthcare | 1.77% | $176.51 | 1.7M | $170.1M |
| 9 | INSMInsmed | Healthcare | 1.76% | $176.28 | 1.2M | $169.9M |
| 10 | AMGNAmgen | Healthcare | 1.75% | $174.96 | 386K | $168.6M |
| 11 | UTHRUnited Therapeutics | Healthcare | 1.73% | $173.10 | 298K | $166.8M |
| 12 | ORKAOruka Therapeutics | Healthcare | 1.68% | $167.60 | 1.7M | $161.5M |
| 13 | BBIOBridgebio Pharma | Healthcare | 1.62% | $161.51 | 2.0M | $155.6M |
| 14 | ALKSAlkermes | Healthcare | 1.60% | $159.87 | 3.3M | $154.1M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 1.59% | $158.64 | 976K | $152.9M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 2.31% |
| 2 | TGTX | TG Therapeutics | 1.87% |
| 3 | BIIB | Biogen | 1.84% |
| 4 | GILD | Gilead Sciences | 1.80% |
| 5 | REGN | Regeneron Pharmaceuticals | 1.79% |
| 6 | EXEL | Exelixis | 1.77% |
| 7 | ABBV | Abbvie | 1.77% |
| 8 | SYRE | Spyre Therapeutics | 1.77% |
| 9 | INSM | Insmed | 1.76% |
| 10 | AMGN | Amgen | 1.75% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 22, 2026 | Jun 24, 2026 | $0.14 |
| Dec 22, 2025 | Dec 24, 2025 | $0.41 |
| Sep 22, 2025 | Sep 24, 2025 | $0.0267 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0073 |
| Mar 24, 2025 | Mar 26, 2025 | $0.0053 |
| Dec 23, 2024 | Dec 26, 2024 | $0.0027 |
| Sep 23, 2024 | Sep 25, 2024 | $0.0152 |
| Jun 24, 2024 | Jun 26, 2024 | $0.11 |
| Dec 18, 2023 | Dec 21, 2023 | $0.0139 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0026 |
| Mar 22, 2021 | Mar 25, 2021 | $0.0400 |
| Dec 21, 2020 | Dec 24, 2020 | $0.18 |